BridgeBio Announces Appointment of Thomas Trimarchi, Ph.D., as President and Chief Operating Officer

July 24, 2024

https://www.globenewswire.com/news-release/2024/07/23/2917111/0/en/BridgeBio-Announces-Appointment-of-Thomas-Trimarchi-Ph-D-as-President-and-Chief-Operating-Officer.html

PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq:BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, announced that Thomas Trimarchi, Ph.D., has been appointed President and Chief Operating Officer (COO) of the company. Dr. Trimarchi will assume his new responsibilities effective immediately and will continue to report directly to CEO and founder, Neil Kumar, Ph.D.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.